Best Edwin Singh Podcasts (2024)

1
Adrian Rawcliffe, Adaptimmune 🇬🇧 | Tecelra, TCR Cell Therapy, Solid Tumors | E22 54:29

9d ago54:29

54:29

We’re online with Adrian Rawcliffe, the CEO of Adaptimmune, the TCR cell therapy company behind the first engineered cell therapy for solid tumors that was approved for a rare form of sarcoma. We talked about Tecelra's commercial rollout. We also talked about what's next in cell therapy, and Philly Cheesesteak vs Fish and Chips. — — —Thank you to t…

1
Marina Udier, Nouscom 🇨🇭 | Cancer Vaccines, Neoantigens | E21 1:19:52

29d ago1:19:52

1:19:52

We’re in Basel 🇨🇭 with the CEO of Nouscom, one of the top EU immuno-oncology biotechs in the cancer vaccine space, Marina Udier.We talked about cancer vaccines and Nouscom’s platform. We also discussed the importance of focus for success and her career.⭐️ ABOUT THE SPEAKERMarina was recommended to me by one of her investors. She has an inspiring st…

1
Harpreet Singh, Immatics 🇩🇪 | PRAME, TCR Based Therapeutics | E20 1:04:02

2M ago1:04:02

1:04:02

We’re in Munich 🇩🇪 with the founder of one of the 15 most valuable European biotechs, Harpreet Singh.We talked about the field of PRAME receptors, TCR therapeutics and cell therapy at large. We also talked about the combination with mRNA therapeutics and his upbringing in a Sikh family in Germany. 🔗 LINKS MENTIONEDLabiotech.eu | “Interview Harpreet…

1
Dominik Schumacher, Tubulis 🇩🇪 | Founder-led ADC Biotech ⭐️ | E19 1:08:38

4M ago1:08:38

1:08:38

We’re in Munich 🇩🇪 with a “true” biotech founder, Dominik Schumacher of Tubulis. Not many biotechs in Europe are led by a founder PhD under 40 and have scaled to raising over 100M. I know only two, one is Thomas at Owkin and the other one is Dominik at Tubulis.We talked about building a champion ADC biotech, the super hot ADC sphere, and the differ…

1
Otello Stampacchia, Omega Funds 🇮🇹 | M&A, Boston & Pasta | E18 1:02:46

4M ago1:02:46

1:02:46

We’re in Boston 🇺🇸 with one of the top VCs, Otello Stampacchia of Omega Funds.We talked about the highest competitive tension in biopharma now that he has ever seen. We also talked about his career, especially the challenges and opportunities he had from moving to Boston over 15 years ago. 💎 ABOUT THE SPEAKER Otello is the founder and managing dire…

1
Christina Takke, V-Bio Ventures 🇧🇪 | Wonder VC Woman | E17 43:45

4M ago43:45

43:45

We’re in San Sebastián 🇪🇸 with one of the top VCs in Europe, Christina Takke from V-Bio Ventures. We talk about her path to get to the top and the benefits of gender diversity for both investing and European biotech as a whole. We also talk about her investment in Argenx when it was only three employees and the venture creation had dropped since 20…

1
Naveed Siddiqi, Novo Holdings 🇬🇧🇩🇰 | Sharp Macro View of EU Biotech | E16 46:16

5M ago46:16

46:16

We’re in San Sebastián 🇪🇸 with Naveed Siddiqi of one of Europe's largest biotech investors, Novo Holdings. We talked about how things really are in European biotech at the moment. We also talked about his upbringing as a second-generation immigrant in the UK and the importance of diversity. I’ve known him since he was a partner at Andera. He is a s…

1
Claudia Ulbrich, Cardior 🇩🇪 | Being the Founder of a Rare €1B Exit | E15 54:34

6M ago54:34

54:34

We’re in Hannover 🇩🇪 with the founder and CEO of Cardior, Claudia Ulbrich We talked about Cardior’s recent €1B exit to Novo Nordisk. We also talk about miRNA and Cardiovascular, and why she earned the funny nickname “Frau Biotech”. 💎 ABOUT THE SPEAKER Claudia has been founding biotechs since the ’90s. She founded her first biotech company, LipoNova…

1
Bahija Jallal, Immunocore 🇬🇧 | Commercial, Diversity, and AI | E14 1:15:45

7M ago1:15:45

1:15:45

We’re super privileged to chat online with Bahija Jallal, the CEO of Immunocore. Immunocore is the largest biotech in the UK and the 5th largest in Europe with a market cap of just over 3 billion dollars. We talk about how Immunocore has helped thousands of cancer patients and has become a commercial biotech. We also talk about why she thinks gende…

1
Edwin Moses | How to build large biotech platforms | E13 1:26:40

8M ago1:26:40

1:26:40

We’re in Brussels with Edwin Moses, the former CEO of one of the most successful platform companies in Europe, Ablynx, now part of Sanofi. We talk about how he feels 5 years after the exit from Ablynx and his lessons. We also talk about the parallels between industrial biotech, AI bio and cell therapy, and how a chairman can help CEOs grow. 💎 ABOUT…

1
Jens Nielsen, BII | How to make translation of life science research work | E12 1:18:34

9M ago1:18:34

1:18:34

We’re in Copenhagen with Jens Nielsen, the CEO of BioInnovation Institute. We will talk about what works best to translate academic research in bio into innovation for humanity, especially how everything is connected. We also talk about how BII is solving some of the main challenges scientist entrepreneurs face and the drawbacks of Novo financing m…

1
Sander van Deventer, VectorY & Forbion | Pioneering gene therapy | E11 59:06

10M ago59:06

59:06

We’re in Amsterdam with Sander van Deventer, the CEO of VectorY. We will talk about VectorY and what’s missing in gene therapy. 💎 ABOUT THE SPEAKERSander has an impressive track record, being a professor, operational biotech founder and a VC. In 1998, he co-founded uniQure, which brought the first gene therapy to the market. He also co-founded the …

1
Thomas Clozel, Owkin | What does AI Biotech really mean | E10 1:20:13

11M ago1:20:13

1:20:13

In an online special, we’re interviewing Thomas Clozal, the co-founder and CEO of Owkin. We talk about scaling AI in biotech and how it feels to be the child of billionaire biotech parents.💎 ABOUT THE SPEAKERThomas founded Owkin in 2016 and I first met him in 2017. At that time, Owkin was still a baby and I wasn’t sure where it would go. Now it’s a…

1
Marc de Garidel, Abivax | How to make two billion 💶 exits ("smoothly") | E09 1:11:33

11M ago1:11:33

1:11:33

Today, I’m in Paris (🇫🇷) to chat with Marc de Garidel, the new CEO of Abivax. We talk about the challenges behind the exits and why Abivax could be a third big success.💎 ABOUT THE SPEAKER Marc is a biopharma veteran with an impressive track record. He has made two billion-dollar exits, was CEO of Ipsen, and has recently made the biggest French IPO …

1
Mike Ward | The Best and the Worst since the 80s in EU Biotech | E08 1:44:25

12M ago1:44:25

1:44:25

Today we're in Munich at BIO-Europe to chat with one of the best commentators in European biotech, Mike Ward. We talk about the best and the worst of the European biotech industry since the 80s.💎 ABOUT THE SPEAKERMike has been in biotech content since the birth of the industry in the 80s. He has worked at BioCentury, Informa/Scrip and now Clarivate…

1
Agnete Fredriksen, Nykode | Being one of the top 50 women in 🇪🇺 bio | E07 1:21:51

1y ago1:21:51

1:21:51

We’re live from Oslo 🇳🇴 to catch up with Agnete Fredriksen, co-founder and CBO of Nykode (ex-Vaccibody). In this episode, we chat about being one of the leading women in bio in Europe, the Nordics, and immunotherapies. 💎 ABOUT THE SPEAKERAgnete founded the immunotherapy company Nykode in 2006 which is now worth around $500M. For her PhD she designe…

1
Rodger Novak, CRISPR Tx | Bringing the first CRISPR drug to the market | E06 1:12:03

1y ago1:12:03

1:12:03

Biotech great Rodger Novak, Co-Founder and Chairman of CRISPR Tx joins us on the show. In this episode, we chat about bringing the first CRISPR drug to the market and why he thinks everything is wrong in bio in Europe besides science. Rodgers’ is a name everyone should know, having made it big in the global biotech scene. I first interviewed him ba…

1
Johannes Fruehauf, BioLabs | Reinventing Incubators For Bio Startups | E05 1:28:43

1+ y ago1:28:43

1:28:43

We’re back live and in Paris 🇫🇷 with our next guest, Johannes Fruehauf. We talk about reinventing the co-working labs for biotech startups, the difficulties of doing business in Europe, profitability in biotech, and much more (see timestamps below). 💎 ABOUT THE SPEAKER Johannes is the President, CEO, and founder of BioLabs, the biggest “incubator”,…

1
Bernat Olle, Vedanta | Where is the Microbiome Industry Now | E04 1:21:51

1+ y ago1:21:51

1:21:51

In a virtual special, we welcome Bernat Olle to the show. We discuss the microbiome space, including Vedanta’s upcoming Phase 3, and how it feels to be a European founder in Boston. Bernat is the CEO and co-founder of Boston-based Vedanta Biosciences, one of the leading microbiome companies. They’ve had a positive Phase 2 trial and recently raised …

1
Ingmar Hoerr, CureVac | Founding a $20B Biotech and Almost Dying as CEO | E03 2:31:51

1+ y ago2:31:51

2:31:51

It’s a treat to welcome Ingmar Hoerr on the show. We chat about building a 20B dollar biotech startup, almost dying on the job, and why people skills are so important in biotech. Ingmar is a pioneer in the EU biotech scene, revolutionizing drug development with mRNA therapeutics. He and his team created the initial technology used in mRNA vaccines …

1
Werner Lanthaler, Evotec | Leading AI in Biotech | E02 1:22:19

1+ y ago1:22:19

1:22:19

It's great to have Werner Lanthaler, the CEO of Evotec, one of the largest biotech research companies in Europe/the world, on the show. We have known each other for almost ten years now. He's not only sharp but also friendly and easy to talk to. In this episode, we chat about leading AI in biotech, the sharing economy in the industry, how to be aut…

1
Antoine Papiernik, Sofinnova | €Billion Biotech Investing With Balance | E01 44:21

1+ y ago44:21

44:21

For our first episode, we catch up with Antoine Papiernik, the chairman of Sofinnova partners, one of the top EU biotech VC funds. We chat about building billion-euro biotechs in Europe, being listed on the Midas list (without letting it go to your head), the importance of being good at selling, being lucky, and how to balance all this with family …